SeekingAlpha · Oct 28, 2026
Corbion N.V. (CSNVY) Q3 2026 Earnings Call Transcript
Corbion N.V. (CSNVY) Q3 2026 Earnings Call October 28, 2026 6:00 AM EDTCompany ParticipantsAlex Sokolowski - Head of Investor RelationsOlivier Rigaud -...
CS
OTC · CSNVY
Corbion N.V.
Basic Materials · Chemicals - Specialty
$29.70
Up+$0.00 (+0.00%)
Updated Nov 4, 2026, 10:03 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.23B
- P/E ratio
- 15.75
- Dividend yield
- 2.44%
- 52-week range
- $18.75 – $30.31
- Volume
- 100
- Avg. volume
- 200
Price performance · CSNVY
CSNVY price history
1M range · 4 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
CSNVY closed at $29.70 after 4 trading sessions, up 6.83% for the selected period.
- Last close
- $29.70
- Period change
- +6.83%
- Period low
- $27.80
- Period high
- $30.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $29.70 | $29.70 | $29.70 | $29.70 | 100 |
| Oct 28, 2026 | $29.25 | $29.25 | $29.25 | $29.25 | 100 |
| Oct 27, 2026 | $29.80 | $30.31 | $29.69 | $30.31 | 631 |
| Oct 20, 2026 | $28.00 | $28.39 | $27.80 | $27.80 | 3.02K |
Latest CSNVY news
The latest Smart Investors Daily articles mentioning CSNVY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
CSNVY research
Overview
Company profile and research snapshot.
Company profile
CORBION NV UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 21, 2026 | BERENBERG | Buy | — |
| Sep 10, 2026 | ODDO BHF | Buy | — |
| Sep 3, 2026 | KBC SECURITIES | Buy | — |
| Aug 26, 2026 | ING FM | Hold | — |
| Jul 31, 2026 | DEGROOF PETERCAM | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 28, 2026
Could Corbion Stock Be Repriced After Q3 Growth And PLA Retention
Corbion released Q3 2026 results that showed strong organic sales growth, with both Functional Ingredients & Solutions and Health & Nutrition contributing, and Health & Nutrition delivering particularly strong performance. Management chose to halt the sale of the PLA business after receiving proposals viewed as undervaluing the unit. The company will continue to develop PLA internally while maintaining full year 2026 guidance, supported by a visible Q4 order book. The focus now turns to how...
Yahoo · Oct 28, 2026
Corbion delivers strong volume-led sales growth and significant margin improvement in Q3; full-year guidance maintained
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the first nine months and third quarter of 2026. Key highlights first nine months 2026: Organic sales growth: +3.9%(Q3: +7.6%) - Volume/mix: +5.3%(Q3: +7.9%) -Price: -1.4%(Q3: -0.3%) Sales: € 971.6 million(Q3: € 340.5 million) Adjusted EBITDA: € 152.9 million(Q3: € 64.1 million) Adjusted EBITDA organic growth: +3.5%(Q3: +28.2%) Operating pr
Yahoo · Oct 19, 2026
Corbion (ENXTAM:CRBN) Stock Could Be A Bargain On Cash Flow
Corbion has delivered a strong share price run in recent years, which now puts a spotlight on what investors are really paying for in terms of its cash flows. With the stock last closing at €23.50, the key issue is whether that market price lines up with what the business is expected to generate in cash over time. Over the past 3 years Corbion has returned 67.9%, which raises the question of how much future cash generation is already reflected in the share price. The company’s valuation now...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
